# PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404

> **NCT01540513** · NA · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 12 (actual)

## Conditions studied

- Glioblastoma Multiforme
- Brain Metastases

## Interventions

- **DRUG:** NM404
- **DRUG:** NM404

## Key facts

- **NCT ID:** NCT01540513
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01540513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01540513, "PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01540513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*